Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs - WPEC
This is an editorial summary of research originally reported by Google Health News. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs WPEC GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Nature Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target statnews.com Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns foxnews.com Fat jabs for all will herald an epidemic
Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs WPEC GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Nature Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target statnews.com Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns foxnews.com Fat jabs for all will herald an epidemic
This summary is based on reporting by Google Health News. For the complete article and full research details, see the original report linked below.
Read the full report at the original source
Google Health NewsWas this finding useful?